The Philadelphia-based insurer reported a 1.2% operating margin in 2023, according to an April 2 press release. The margin was “due in part to strong investment income,” the company said.
Independence Blue Cross reported revenues of $31.1 billion in 2023, up 13.6% from 2022. Revenue gains were offset by rising utilization of high-cost drugs, including GLP-1 drugs for diabetes and weight loss, the company said. Year-over-year increases in medical costs also offset gains.
The company’s medical loss ratio in 2023 was 87.8%.
Other Blue Cross Blue Shield companies have reported rising costs from utilization of high-cost drugs, increasing outpatient procedures and rising utilization rates in the Medicare Advantage population.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 17–19 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
